189 results on '"Teirstein, Paul S."'
Search Results
2. LDL to HDL ratio predicts an association with percutaneous coronary interventions.
3. Long-Term Safety and Efficacy of Platinum Chromium Everolimus-Eluting Stents in Coronary Artery Disease: 5-Year Results From the PLATINUM Trial
4. North American Expert Review of Rotational Atherectomy
5. Risk Assessment in Patient Selection for Transcatheter Aortic Valve Replacement
6. Japanese and non-Japanese patient outcomes in the PLATINUM randomized trial comparing the PROMUS Element and XIENCE V everolimus-eluting stents
7. Three-Year Results Comparing Platinum-Chromium PROMUS Element and Cobalt-Chromium XIENCE V Everolimus-Eluting Stents in De Novo Coronary Artery Narrowing (from the PLATINUM Trial)
8. Transapical Aortic Valve Replacement for Severe Aortic Stenosis: Results From the Nonrandomized Continued Access Cohort of the PARTNER Trial
9. Five-year follow-up of the Sirolimus-Eluting Stents vs Vascular Brachytherapy for Bare Metal In-Stent Restenosis (SISR) trial
10. Percutaneous Coronary Intervention Use in the United States: Defining Measures of Appropriateness
11. Engineered virus-like nanoparticles reverse heparin anticoagulation more consistently than protamine in plasma from heparin-treated patients
12. Influence of smoking on the antiplatelet effect of clopidogrel differs according to clopidogrel dose: Insights from the GRAVITAS trial
13. One-year results of the ICON (ionic versus non-ionic contrast to obviate worsening nephropathy after angioplasty in chronic renal failure patients) Study
14. Pilot Study of the Antiplatelet Effect of Increased Clopidogrel Maintenance Dosing and Its Relationship to CYP2C19 Genotype in Patients With High On-Treatment Reactivity
15. Comparison of Long-Term (4-Year) Outcomes of Patients With Unprotected Left Main Coronary Artery Narrowing Treated With Drug-Eluting Stents Versus Coronary-Artery Bypass Grafting
16. Identifying the “Optimal” Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Revascularization
17. The Role of Maintenance of Certification Programs in Governance and Professionalism
18. Ionic Low-Osmolar Versus Nonionic Iso-Osmolar Contrast Media to Obviate Worsening Nephropathy After Angioplasty in Chronic Renal Failure Patients: The ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) Study
19. Predictors of Heightened Platelet Reactivity Despite Dual-Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention
20. 3-Year Follow-Up of the SISR (Sirolimus-Eluting Stents Versus Vascular Brachytherapy for In-Stent Restenosis) Trial
21. Unprotected Left Main Intervention: Patient Selection, Operator Technique, and Clinical Outcomes
22. A collaborative systematic review and meta-analysis on 1278 patients undergoing percutaneous drug-eluting stenting for unprotected left main coronary artery disease
23. Usefulness of Proteinuria as a Prognostic Marker of Mortality and Cardiovascular Events Among Patients Undergoing Percutaneous Coronary Intervention (Data from the Evaluation of Oral Xemilofiban in Controlling Thrombotic Events [EXCITE] Trial)
24. Dynamics of Platelet Functional Recovery Following a Clopidogrel Loading Dose in Healthy Volunteers
25. Two-year safety and effectiveness of the platinum chromium everolimus-eluting stent for the treatment of small vessels and longer lesions
26. Efficacy and Safety of Triple Antiplatelet Therapy With and Without Concomitant Anticoagulation During Elective Percutaneous Coronary Intervention (the REMOVE Trial)
27. Safety of Sirolimus-Eluting Stenting and Its Effect on Restenosis in Patients With Unstable Angina Pectoris (a SIRIUS Substudy)
28. Procedural Effectiveness of a Novel 1.20 mm Diameter Angioplasty Catheter: Clinical and Angiographic Outcomes
29. Restenosis after angioplasty
30. Early- and Medium-Term Outcomes After Paclitaxel-Eluting Stent Implantation for Sirolimus-Eluting Stent Failure
31. Onset and Offset of Platelet Inhibition After High-Dose Clopidogrel Loading and Standard Daily Therapy Measured by a Point-of-Care Assay in Healthy Volunteers
32. Differential Effects Between Intravenous and Targeted Renal Delivery of Fenoldopam on Renal Function and Blood Pressure in Patients Undergoing Cardiac Catheterization
33. Two-Year Outcomes after Transcatheter or Surgical Aortic-Valve Replacement
34. Standard- vs High-Dose Clopidogrel Based on Platelet Function Testing After Percutaneous Coronary Intervention: The GRAVITAS Randomized Trial
35. Clinical Outcomes Following Predilation with a Novel 1.25-mm Diameter Angioplasty Catheter
36. Dual catheter technique for the treatment of severe coronary artery perforations
37. Safety and Performance of Targeted Renal Therapy: The Be-RITe! Registry
38. Two-year clinical follow-up of 90Sr/ 90 Y β-radiation versus placebo control for the treatment of in-stent restenosis
39. Comparison of Thrombosis and Restenosis Risk from Stent Length of Sirolimus-Eluting Stents Versus Bare Metal Stents
40. Effect of Combined Anticoagulation and Low-Dose Aspirin Treatment on Upper Gastrointestinal Bleeding
41. Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation
42. Intracoronary Radiation Therapy for Multi-Drug Resistant in-Stent Restenosis: Initial Clinical Experience
43. Direct Thrombin Inhibition Appears to be a Safe and Effective Anticoagulant for Percutaneous Bypass Graft Interventions
44. Percutaneous recanalization of chronically occluded coronary arteries: Procedural techniques, devices, and results
45. Clinical outcomes after sirolimus-eluting stent implantation for de novo saphenous vein graft lesions
46. Aspirin Sensitivity: Implications for Patients With Coronary Artery Disease
47. Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary Artery
48. Localized Intracoronary Gamma-Radiation Therapy to Inhibit the Recurrence of Restenosis after Stenting
49. Evaluation of individualized clopidogrel therapy after drug-eluting stent implantation in patients with high residual platelet reactivity: Design and rationale of the GRAVITAS trial
50. Effect of catheter-based iridium-192 gamma brachytherapy on the added risk of restenosis from diabetes mellitus after intervention for in-stent restenosis (subanalysis of the GAMMA I Randomized Trial)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.